CORVALLIS, OR--(Marketwire - November 04, 2008) - AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that Leslie Hudson, Ph.D., president and chief executive officer of AVI BioPharma, will present a company overview at the Rodman & Renshaw Annual Global Investment Conference in New York City on Tuesday, November 11, 2008 at 9:30 a.m. ET.
